Finance

Lists
Why is INTS down 2.99%?
Dive Deeper
INTS:NASDAQ
Intensity Therapeutics Inc
$3.25
-2.99%
(-0.100) 1D
Oct 19, 1:14:29 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTS...
Open
$3.21
High
$3.30
Low
$3.19
Mkt. cap
10.61M
Avg. vol.
20.92K
Volume
4.51K
52-wk high
$43.50
52-wk low
$3.10
EPS
-$4.93
Beta
3.06
Shares outstanding
3.26M
No. of employees
5
Open
$3.21
High
$3.30
Low
$3.19
Mkt. cap
10.61M
Avg. vol.
20.92K
Volume
4.51K
52-wk high
$43.50
52-wk low
$3.10
EPS
-$4.93
Beta
3.06
Shares outstanding
3.26M
No. of employees
5
News stories
From web sources and news partners
About Intensity Therapeutics Inc
CEO-
Employees5
Founded2012
HeadquartersShelton, Connecticut, United States
SectorBiotechnology
Websiteintensitytherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to INTS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INTS in the last 3 months.
Highest
Current $3.25
$15.00 (+361.54%)
Average
$11.00 (+238.46%)
Lowest
$7.00 (+115.38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$7.00
+115.4%
08/20/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$15.00
+361.5%
08/11/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Upgraded
$20.00
+515.4%
03/30/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$30.00
+823.1%
03/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.55M
1.50M
1.20M
1.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.18M
1.64M
1.33M
1.25M
Operating expense
2.73M
3.14M
2.53M
3.08M
Total operating expenses
2.73M
3.14M
2.53M
3.08M
Operating income
-2.73M
-3.14M
-2.53M
-3.08M
Other non operating income
3.00K
1.00K
-2.00K
-
EBT including unusual items
-2.67M
-3.05M
-2.43M
-3.01M
EBT excluding unusual items
-2.67M
-3.05M
-2.43M
-3.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.67M
-3.05M
-2.43M
-3.01M
Net profit margin
-
-
-
-
Earnings per share
-1.50
-
-0.96
-1.11
Interest and investment income
59.00K
88.00K
94.00K
77.00K
Interest expense
-
-
-
-
Net interest expenses
59.00K
88.00K
94.00K
77.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps